Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances M Bashore

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Virology|March 11, 2025
BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cellsAnne-Marie W Turner, Frances M Bashore, Shane D Falcinelli, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2Zachary W Davis-Gilbert, Andreas Krämer, James E Dunford, et al.
Frontiers in Chemical Biology|April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function VariantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
ACS Chemical Biology|March 6, 2023
PROTAC Linkerology Leads to an Optimized Bivalent Chemical Degrader of Polycomb Repressive Complex 2 (PRC2) ComponentsFrances M Bashore, Caroline A Foley, Han Wee Ong, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
European Journal of Medicinal Chemistry|March 8, 2026
Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5Xiaowen Wang, Feijun Wang, Deyu Kong, et al.
The Journal of Biological Chemistry|October 22, 2023
Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's diseaseYuhong Du, William J Bradshaw, Tina M Leisner, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's diseaseYuhong Du, William J Bradshaw, Tina M Leisner, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Virology|March 11, 2025
BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cellsAnne-Marie W Turner, Frances M Bashore, Shane D Falcinelli, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2Zachary W Davis-Gilbert, Andreas Krämer, James E Dunford, et al.
Frontiers in Chemical Biology|April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function VariantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
ACS Chemical Biology|March 6, 2023
PROTAC Linkerology Leads to an Optimized Bivalent Chemical Degrader of Polycomb Repressive Complex 2 (PRC2) ComponentsFrances M Bashore, Caroline A Foley, Han Wee Ong, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
European Journal of Medicinal Chemistry|March 8, 2026
Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5Xiaowen Wang, Feijun Wang, Deyu Kong, et al.
The Journal of Biological Chemistry|October 22, 2023
Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's diseaseYuhong Du, William J Bradshaw, Tina M Leisner, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's diseaseYuhong Du, William J Bradshaw, Tina M Leisner, et al.
Pageof 3